Allergy to polyethylene glycol (PEG) ingredient in Pfizer COVID 19 vaccine: Diagnostic challenge

被引:0
|
作者
Katre, Mahesh [1 ]
Traves, Donna [1 ]
机构
[1] Royal Derby Hosp, Derby, England
来源
CLINICAL AND EXPERIMENTAL ALLERGY | 2022年 / 52卷 / 08期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P113
引用
收藏
页码:1057 / 1057
页数:1
相关论文
共 50 条
  • [43] Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
    Kozma, Gergely Tibor
    Meszaros, Tamas
    Berenyi, Petra
    Facsko, Reka
    Patko, Zsofia
    Olah, Csaba Zs.
    Nagy, Adrienne
    Fueloep, Tamas Gyula
    Glatter, Kathryn Anne
    Radovits, Tamas
    Merkely, Bela
    Szebeni, Janos
    VACCINE, 2023, 41 (31) : 4561 - 4570
  • [44] COVID-19 mRNA vaccine allergy
    Risma, Kimberly A.
    CURRENT OPINION IN PEDIATRICS, 2021, 33 (06) : 610 - 617
  • [45] Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients
    Bruusgaard-Mouritsen, Maria A.
    Johansen, Jeanne D.
    Garvey, Lene H.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (03): : 463 - 470
  • [46] Successful delivery of mRNA COVID-19 vaccine to high-risk children aged 12+with a history of immediate reaction to polyethylene glycol (PEG)
    Cloonan, Jeanne
    Crealey, Miranda
    Whooley, Paul
    Alsaleemi, Ali
    Fitzpatrick, Maura
    Evans, Pamela
    Malone, Andrea
    O'Marcaigh, Aengus
    Kelleher, Maeve
    Byrne, Aideen
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1054 - 1055